These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21387196)

  • 1. The antithrombotic management of patients on oral anticoagulation undergoing coronary stent implantation: an update.
    Rubboli A
    Intern Emerg Med; 2012 Aug; 7(4):299-304. PubMed ID: 21387196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies.
    Barbieri L; Verdoia M; Schaffer A; Suryapranata H; De Luca G
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):611-622. PubMed ID: 27757726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) Registry.
    Rubboli A; Saia F; Sciahbasi A; Bacchi-Reggiani ML; Steffanon L; Briguori C; Calabrò P; Palmieri C; Rizzi A; Imperadore F; Sangiorgi GM; Valgimigli M; Carosio G; Steffenino G; Galvani M; Di Pasquale G; La Vecchia L; Maggioni AP; Bolognese L;
    J Invasive Cardiol; 2014 Nov; 26(11):563-9. PubMed ID: 25363997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment.
    Zhao HJ; Zheng ZT; Wang ZH; Li SH; Zhang Y; Zhong M; Zhang W
    Chest; 2011 Feb; 139(2):260-270. PubMed ID: 21285053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary stent implantation in patients committed to long-term oral anticoagulation therapy: successfully navigating the treatment options.
    Rubboli A; Kovacic JC; Mehran R; Lip GYH
    Chest; 2011 May; 139(5):981-987. PubMed ID: 21540213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do you do with the antiplatelet agents in patients with drug eluting stents who then receive a mechanical valve?
    Rossi M; Serraino GF; Spadafora A; Renzulli A
    Interact Cardiovasc Thorac Surg; 2012 Jul; 15(1):115-21. PubMed ID: 22457187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
    Manzano-Fernández S; Pastor FJ; Marín F; Cambronero F; Caro C; Pascual-Figal DA; Garrido IP; Pinar E; Valdés M; Lip GYH
    Chest; 2008 Sep; 134(3):559-567. PubMed ID: 18641090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve-month outcome of patients with an established indication for oral anticoagulation undergoing coronary artery stenting and stratified by the baseline risk of bleeding: Insights from the Warfarin and Coronary Stenting (War-Stent) Registry.
    Rubboli A; Saia F; Sciahbasi A; Leone AM; Palmieri C; Bacchi-Reggiani ML; Calabrò P; Bordoni B; Piccalò G; Franco N; Nicolino A; Magnavacchi P; Vignali L; Mameli S; Dallago M; Maggiolini S; Steffanon L; Piovaccari G; Di Pasquale G;
    Cardiovasc Revasc Med; 2017 Sep; 18(6):425-430. PubMed ID: 28363682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New aspects on "triple therapy" after coronary stent implantation].
    Schlitt A
    Dtsch Med Wochenschr; 2010 Oct; 135(41):2033-6. PubMed ID: 20925012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
    Rubboli A; Agewall S; Huber K; Lip GY
    Int J Cardiol; 2015 Oct; 196():133-8. PubMed ID: 26093527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Gao F; Zhou YJ; Wang ZJ; Shen H; Liu XL; Nie B; Yan ZX; Yang SW; Jia de A; Yu M
    Circ J; 2010 Apr; 74(4):701-8. PubMed ID: 20208381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation.
    Sarafoff N; Ndrepepa G; Mehilli J; Dörrler K; Schulz S; Iijima R; Byrne R; Schömig A; Kastrati A
    J Intern Med; 2008 Nov; 264(5):472-80. PubMed ID: 18624903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term efficacy and safety of triple vs. dual antithrombotic therapy in patients with drug-eluting stent implantation and an indication for oral anticoagulation: a meta-analysis.
    Cao Y; Tian XY; Zhang R; Zhao JQ; Zhang M; Cheng YT; Li CF; Liu GL; An Y
    Int J Clin Pharmacol Ther; 2016 Dec; 54(12):950-965. PubMed ID: 27641219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
    Smith JG; Wieloch M; Koul S; Braun OÖ; Lumsden J; Rydell E; Ohman J; Scherstén F; Svensson PJ; van der Pals J
    EuroIntervention; 2012 Oct; 8(6):672-8. PubMed ID: 23086784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
    Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
    Helft G; Gilard M; Le Feuvre C; Zaman AG
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.